Best- and Worst-Performing Stocks of November 2024
Palantir and AppLovin rank among the best stocks for the month, while the worst include Monolithic Power and Booz Allen Hamilton.
The Morningstar US Large-Mid Cap Index rose 6.3% in November amid a rally in the financial services sector. The Large-Mid Index tracks the performance of the top 90% of the US investable universe by market cap, and each month, we screen it to find the best- and worst-performing companies. Data in this article is sourced from Morningstar Direct.
Best-Performing Stocks of November 2024
Worst-Performing Stocks of November 2024
Best-Performing US Stocks for November 2024
Metrics for the Best-Performing Stocks
AppLovin
- Sector: Technology
- Industry: Software - Application
- Economic Moat: Not Rated
AppLovin jumped 98.8% in November, bringing the stock up 798.5% over the past year. The company’s stock has a quantitative Morningstar Rating of 1 star.
Coinbase Global
- Sector: Financial Services
- Industry: Financial Data & Stock Exchanges
- Economic Moat: None
Coinbase advanced 65.2%, leaving the stock up 137.5% for the year. Shares are 13.3% below their last high on Nov. 20, 2024. The company’s stock has a Morningstar Rating of 1 star and trades at a 97% premium to its fair value estimate of $150 per share.
Palantir Technologies
- Sector: Technology
- Industry: Software - Infrastructure
- Economic Moat: Narrow
Palantir advanced 61.4%, bringing the stock up 234.6% over the past year. The company’s stock has a Morningstar Rating of 1 star and trades at a 219% premium to its fair value estimate of $21 per share.
Robinhood Markets
- Sector: Financial Services
- Industry: Capital Markets
- Economic Moat: Not Rated
Robinhood rallied 59.8%, having risen 326.6% from one year ago. The company’s stock has a quantitative Morningstar Rating of 3 stars.
MicroStrategy
- Sector: Technology
- Industry: Software - Application
- Economic Moat: Not Rated
MicroStrategy climbed 58.5%, bringing the stock up 677.6% over the past year. Shares are 28.6% below their last high on Nov. 21, 2024. The company’s stock has a quantitative Morningstar Rating of 1 star.
Worst-Performing US Stocks for November 2024
Metrics for the Worst-Performing Stocks
Celanese
- Sector: Basic Materials
- Industry: Chemicals
- Economic Moat: Narrow
Celanese tumbled 41.9% in November, having fallen 46.2% from one year ago. Shares are 57.5% below their last high on March 28, 2024. The company’s stock has a Morningstar Rating of 5 stars and is trading at a 51% discount on its fair value estimate of $150 per share.
Monolithic Power Systems
- Sector: Technology
- Industry: Semiconductors
- Economic Moat: Wide
Monolithic Power slid 25.2% but was still up 4.1% over the past year. Shares are 40.8% below their last high on Aug. 29, 2024. The company’s stock has a Morningstar Rating of 4 stars and is trading at a 19% discount to its fair value estimate of $700 per share.
Moderna
- Sector: Healthcare
- Industry: Biotechnology
- Economic Moat: None
Moderna slid 20.8%, leaving the stock down 44.6% for the year. Shares are 74.7% below their last high on May 24, 2024. The company’s stock has a Morningstar Rating of 5 stars and is trading at a 69% discount to its fair value estimate of $141 per share.
AES
- Sector: Utilities
- Industry: Utilities - Diversified
- Economic Moat: None
AES slid 20.0% and declined 21.0% over the past year. Shares are 41.3% below their last high on May 31, 2024. The company’s stock has a Morningstar Rating of 4 stars and is trading at a 19% discount to its fair value estimate of $16 per share.
Booz Allen Hamilton
- Sector: Industrials
- Industry: Consulting Services
- Economic Moat: Not Rated
Booz Allen Hamilton fell 18.2% but was still up 20.1% from one year ago. Shares are 22.3% below their last high on Nov. 6, 2024. The company’s stock has a quantitative Morningstar Rating of 3 stars.
Companies that are not formally covered by a Morningstar analyst are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative star rating.
This article was generated with the help of automation and reviewed by Morningstar editors. Learn more about Morningstar’s use of automation.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
United States